Evidence map›Paper›PMID 32087815›Full record

SynthesisThe Lancet. Global health2020

Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study.

Xin Wang, You Li, Katherine L O'Brien, Shabir A Madhi, Marc-Alain Widdowson, Peter Byass, Saad B Omer, Qalab Abbas, Asad Ali, Alberta Amu and 39 more

Registry-linked trialOpen access · goldAbstract readSystematic Review
In one paragraph

Synthesis in The Lancet. Global health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05378022 (Application of LiveSpo Navax in Treatment of Acute Respiratory Disease in Children Infected With Influenza Virus), which is not on this map. Cited by 277 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
277citing papers in PubMed, 8 pooled it
38.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05378022 nacompletednot on this map

Application of LiveSpo Navax in Treatment of Acute Respiratory Disease in Children Infected With Influenza Virus

TypeinterventionalSponsorNational Children's Hospital, VietnamRan2020 to 2022Enrolled70ConditionsAcute Respiratory Tract InfectionsArmsLiveSpo Navax, 0.9% NaCl physiological saline
3 · Its place in the literature

Who cites it

277 citing papers in PubMed, 8 syntheses or guidelines pooled it, 474 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Myeloid TLR2 signaling amplifies immunopathology in influenza-infected murine neonates.American journal of respiratory cell and molecular biology · 2026
    Article
  19. Article
  20. Article

217 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

49 authors at 20 institutions in 23 countries.

Xin WangCentre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.
You LiCentre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.
Katherine L O'BrienDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Shabir A MadhiMedical Research Council: Respiratory and Meningeal Pathogens Research Unit; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Marc-Alain WiddowsonDivision of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Nairobi, Kenya; Institute of Tropical Medicine, Antwerp, Belgium.
Peter ByassDepartment of Epidemiology and Global Health, Umeå University, Umeå, Sweden.
Saad B OmerYale Institute for Global Health; Section of Infectious Diseases, Department of Medicine, Yale School of Medicine; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Qalab AbbasDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Asad AliDepartment of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Alberta AmuDodowa Health Research Centre, Dodowa, Ghana.
Eduardo Azziz-BaumgartnerInfluenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Quique BassatBarcelona Global Health Institute, Hospital Clínic-University of Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain; Pediatric Infectious Diseases Unit, Pediatrics Department, Hospital Sant Joan de Déu (University of Barcelona), Barcelona, Spain; Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública, Madrid, Spain.
W Abdullah BrooksDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Sandra S ChavesInfluenza Program, Centers for Disease Control and Prevention, Nairobi, Kenya.
Alexandria ChungCentre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.
Cheryl CohenCentre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Marcela EchavarriaClinical Virology Unit, Centro de Educación Médica e Investigaciones Clínicas, Argentina.
Rodrigo A FascePublic Health Institute of Chile, Región Metropolitana, Chile.
Angela GentileRicardo Gutierrez Children Hospital, Buenos Aires, Argentina.
Aubree GordonDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Michelle GroomeMedical Research Council: Respiratory and Meningeal Pathogens Research Unit; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Terho HeikkinenDepartment of Pediatrics, University of Turku and Turku University Hospital, Finland.
Siddhivinayak HirveVadu Rural Health program, KEM Hospital Research Centre, Pune, Maharashtra, India.
Jorge H JaraCenter for Health Studies, Universidad del Valle de Guatemala, Guatemala City, Guatemala.
Mark A KatzChief Physician's Office, Clalit Health Services, Clalit Research Institute, Tel Aviv, Israel; Ben Gurion University of the Negev, School of Public Health and Medical School for International Health, Beer-Sheva, Israel; University of Michigan School of Public Health, Ann Arbor, MI, USA.
Najwa Khuri-BulosDepartment of Pediatrics, University of Jordan School of Medicine, Amman, Jordan.
Anand KrishnanCentre for Community Medicine, All India Institute of Medical Sciences, New Delhi, India.
Oscar de LeonCenter for Health Studies, Universidad del Valle de Guatemala, Guatemala City, Guatemala.
Marilla G LuceroARI Study Group, Research Institute for Tropical Medicine, Muntinlupa, Philippines.
John P McCrackenCenter for Health Studies, Universidad del Valle de Guatemala, Guatemala City, Guatemala.
Ainara Mira-IglesiasÁrea de Investigación en Vacunas, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (Salud Pública), Valencia, Spain.
Jennifer C MoïsiAgence de Médecine Préventive, Paris, France.
Patrick K MunywokiKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Millogo OurohiréCentre de Recherche en Santé de Nouna, Nouna, Burkina Faso.
Fernando P PolackFundacion INFANT, Buenos Aires, Argentina.
Manveer RahiCentre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.
Zeba A RasmussenFogarty International Center, National Institutes of Health, Bethesda, MD, USA.
Barbara A RathVienna Vaccine Safety Initiative, Berlin, Germany.
Samir K SahaDepartment of Microbiology, Child Health Research Foundation, Dhaka, Bangladesh.
Eric Af SimõesDepartment of Pediatrics, Section of Infectious Diseases, University of Colorado, School of Medicine, Aurora, CO, USA; Department of Epidemiology and Center for Global Health, Colorado School of Public Health, Aurora CO, USA.
Viviana SotomayorEpidemiology Department, Ministry of Health, Santiago, Chile.
Somsak ThamthitiwatDivision of Global Health Protection, Thailand Ministry of Public Health; US CDC Collaboration, Nonthaburi, Thailand.
Florette K TreurnichtDepartment of Medical Virology, National Health Laboratory Service and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Marylene WamukoyaAfrican Population & Health Research Center, Nairobi, Kenya.
Lay-Myint YoshidaDepartment of Pediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
Heather J ZarDepartment of Paediatrics & Child Health and Medical Research Council unit on Child & Adolescent Health, University of Cape Town, Cape Town, South Africa.
Harry CampbellCentre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.
Harish NairCentre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK. Electronic address: harish.nair@ed.ac.uk.
Respiratory Virus Global Epidemiology Network
University of Edinburgh · GBUniversidad del Valle de Guatemala · GTUniversity of the Witwatersrand · ZAAga Khan University · PKCenters for Disease Control and Prevention · KEJohns Hopkins University · USChild Health Research Foundation · BDHospital General de Niños Ricardo Gutierrez · ARAfrican Population and Health Research Center · KEAgence de Médecine Préventive · FRAll India Institute of Medical Sciences · INBen-Gurion University of the Negev · ILCenters for Disease Control and Prevention · USCentre de Recherche en Santé de Nouna · BFCentro de Educación Médica e Investigaciones Clínicas Norberto Quirno · ARColorado School of Public Health · USDodowa Health Research Centre · GHDr. D. Y. Patil Medical College, Hospital and Research Centre · INFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESInfant Foundation · AR

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
ACL HHS U01GH001003CGH CDC HHS U01 GH000028CGH CDC HHS U01 GH001003NCATS NIH HHS UL1 TR001863Wellcome Trust
6 · The paper itself

Abstract

backgroundSeasonal influenza virus is a common cause of acute lower respiratory infection (ALRI) in young children. In 2008, we estimated that 20 million influenza-virus-associated ALRI and 1 million influenza-virus-associated severe ALRI occurred in children under 5 years globally. Despite this substantial burden, only a few low-income and middle-income countries have adopted routine influenza vaccination policies for children and, where present, these have achieved only low or unknown levels of vaccine uptake. Moreover, the influenza burden might have changed due to the emergence and circulation of influenza A/H1N1pdm09. We aimed to incorporate new data to update estimates of the global number of cases, hospital admissions, and mortality from influenza-virus-associated respiratory infections in children under 5 years in 2018.

methodsWe estimated the regional and global burden of influenza-associated respiratory infections in children under 5 years from a systematic review of 100 studies published between Jan 1, 1995, and Dec 31, 2018, and a further 57 high-quality unpublished studies. We adapted the Newcastle-Ottawa Scale to assess the risk of bias. We estimated incidence and hospitalisation rates of influenza-virus-associated respiratory infections by severity, case ascertainment, region, and age. We estimated in-hospital deaths from influenza virus ALRI by combining hospital admissions and in-hospital case-fatality ratios of influenza virus ALRI. We estimated the upper bound of influenza virus-associated ALRI deaths based on the number of in-hospital deaths, US paediatric influenza-associated death data, and population-based childhood all-cause pneumonia mortality data in six sites in low-income and lower-middle-income countries.

findingsIn 2018, among children under 5 years globally, there were an estimated 109·5 million influenza virus episodes (uncertainty range [UR] 63·1-190·6), 10·1 million influenza-virus-associated ALRI cases (6·8-15·1); 870 000 influenza-virus-associated ALRI hospital admissions (543 000-1 415 000), 15 300 in-hospital deaths (5800-43 800), and up to 34 800 (13 200-97 200) overall influenza-virus-associated ALRI deaths. Influenza virus accounted for 7% of ALRI cases, 5% of ALRI hospital admissions, and 4% of ALRI deaths in children under 5 years. About 23% of the hospital admissions and 36% of the in-hospital deaths were in infants under 6 months. About 82% of the in-hospital deaths occurred in low-income and lower-middle-income countries.

interpretationA large proportion of the influenza-associated burden occurs among young infants and in low-income and lower middle-income countries. Our findings provide new and important evidence for maternal and paediatric influenza immunisation, and should inform future immunisation policy particularly in low-income and middle-income countries.

fundingWHO; Bill & Melinda Gates Foundation.

Indexed as

Child, PreschoolGlobal HealthHumansInfantInfant, NewbornInfluenza, HumanLinear ModelsRespiratory Tract InfectionsSeasons

Identifiers

PMID32087815
PMCPMC7083228
OpenAlexW3007834947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.